Literature DB >> 23628329

Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides Mehran risk score, in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention?

Ahmet Çağrı Aykan1, Ilker Gül, Tayyar Gökdeniz, Ezgi Kalaycıoğlu, Turhan Turan, Faruk Boyacı, Hakan Erkan, Engin Hatem, Duygun Altıntaş Aykan, Sükrü Celik.   

Abstract

BACKGROUND: The association of coronary artery disease complexity with contrast induced nephropathy (CIN) in patients with acute ST segment elevation myocardial infarction (STEMI) is inadequately evaluated and to our knowledge the association between SYNTAX score (SS) and Mehran score (MS) have not been studied. The aim of the present study is to clarify the incidence of CIN and to identify demographic, clinical and procedural variables associated with CIN in patients who underwent primary percutaneous coronary intervention (PPCI) due to acute STEMI, besides the association between MS and SS with CIN.
METHODS: We analysed the clinical data of 402 patients (309 male, 93 female, mean age 63.8 ± 12.65 year) with 179 (44.5%) anterior MI, 104 (25.9%) inferior MI, 119 (29.6%) inferior MI with right ventricular involvement who underwent PPCI.
RESULTS: We found that CIN was observed in 32.6% of patients. The SS (OR=1.037, %95CI=1.012-1.062, p=0.003), MS (OR=1.072, %95CI=1.025-1.121, p=0.003), HDL (OR=0.974, %95CI=0.949-0.999, p=0.044) were the independent predictors of CIN. The cut off value to show CIN for SS was 31.5 (sensitivity=79.4%, specificity=88.6%) and MS was 12.5 (sensitivity=73.3%, specificity=88.9%) in ROC curve analysis.
CONCLUSION: In conclusion, besides MS, SS may be a valuable marker to identify patients at high risk for CIN in patients undergoing primary percutaneous intervention.
Copyright © 2013 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contrast; Coronary; Mehran score; Myocardial infarction; Nephropathy; SYNTAX score

Mesh:

Substances:

Year:  2013        PMID: 23628329     DOI: 10.1016/j.hlc.2013.03.085

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  5 in total

1.  Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.

Authors:  Yu-mei Gao; Di Li; Hong Cheng; Yi-pu Chen
Journal:  Clin Exp Nephrol       Date:  2014-02-11       Impact factor: 2.801

2.  Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.

Authors:  Yong Liu; Yuan-Hui Liu; Ji-Yan Chen; Ning Tan; Ying-Ling Zhou; Chong-Yang Duan; Dan-Qing Yu; Nian-Jin Xie; Hua-Long Li; Ping-Yan Chen
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

3.  Association of Syntax Score II with Contrast-induced Nephropathy and Hemodialysis Requirement in Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Ibrahim Rencuzogullari; Metin Çağdaş; Süleyman Karakoyun; Yavuz Karabağ; Mahmut Yesin; Mustafa Ozan Gürsoy; İnanç Artaç; Doğan İliş; Süleyman Çağan Efe; Kevser Tural; Ibrahim Halil Tanboğa
Journal:  Korean Circ J       Date:  2017-11-15       Impact factor: 3.243

4.  The relation between intensity and complexity of coronary artery lesion and oxidative stress in patients with acute coronary syndrome.

Authors:  Turhan Turan; Ümit Menteşe; Mustafa Tarık Ağaç; Ali Rıza Akyüz; Selim Kul; Ahmet Çağrı Aykan; Hüseyin Bektaş; Levent Korkmaz; Seda Öztaş Menteşe; İhsan Dursun; Şükrü Çelik
Journal:  Anatol J Cardiol       Date:  2014-10-15       Impact factor: 1.596

5.  Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome.

Authors:  Luis F Reyes; Diego F Severiche-Bueno; Carlos A Bustamante; Sixta Murillo; Nilam J Soni; Marcela Poveda; Efraín Gomez; Ricardo Buitrago; Alejandro Rodriguez
Journal:  BMC Nephrol       Date:  2020-04-22       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.